Literature DB >> 30632282

Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.

Shinichi Ikuta1, Tsukasa Aihara1, Naoki Yamanaka1.   

Abstract

AIM: Systemic inflammation and nutritional status are associated with clinical outcomes of cancer patients. We investigated the prognostic value of preoperative C-reactive protein to albumin ratio (CAR) in patients with pancreatic ductal adenocarcinoma (PDA) after pancreatic resection.
METHODS: One-hundred and thirty-six PDA patients who underwent pancreatic resection between January 2005 and June 2017 were retrospectively enrolled. Preoperative inflammation-based scores including CAR, modified Glasgow prognostic score (mGPS), neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte to monocyte ratio (LMR) and prognostic nutritional index (PNI) were evaluated as potential predictor of overall survival (OS) using Cox regression models. An optimal cutoff value for the continuous variable was estimated by receiver-operating characteristic (ROC) analysis.
RESULTS: Patients were categorized by CAR using a cutoff value of 0.09. High CAR was associated with advanced stage, increased mGPS and decreased LMR and PNI, but not with other factors such as tumor location, preoperative biliary drainage or preoperative chemotherapy. In univariate analysis, patients with high CAR had poor OS compared with those with low CAR (P = 0.01). Multivariate analysis indicated that high CAR was an independent predictor of poor OS (P = 0.03) in addition to advanced stage and residual tumors. The predictive ability of CAR evaluated by area under the ROC curve was consistently higher than that of other inflammation-based factors.
CONCLUSION: Preoperative CAR was an independent and superior predictor of survival after pancreatic resection in patients with PDA. [Correction added on 17 January 2019, after first online publication: In Conclusion, "in" has been corrected to "independent" for clarity.].
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  C-reactive protein to albumin ratio; pancreatic ductal adenocarcinoma; pancreatic resection

Mesh:

Substances:

Year:  2019        PMID: 30632282     DOI: 10.1111/ajco.13123

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  11 in total

1.  Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.

Authors:  Wen Fu; Kun Wang; Shan Yan; Xie Wang; Bo Tang; Jiang Chang; Ran Wang; Tao Wu
Journal:  Dose Response       Date:  2020-08-03       Impact factor: 2.658

2.  The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.

Authors:  Huan Zhang; Dianyun Ren; Xin Jin; Heshui Wu
Journal:  Cancer Cell Int       Date:  2020-09-22       Impact factor: 5.722

3.  The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study.

Authors:  Jovan Vujic; Katharina Marsoner; Valerie Wienerroither; Hans-Jorg Mischinger; Peter Kornprat
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

4.  Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.

Authors:  Qinfen Xie; Lidong Wang; Shusen Zheng
Journal:  Dose Response       Date:  2020-06-29       Impact factor: 2.658

5.  Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.

Authors:  Shuwen Lin; Yinghua Fang; Zhikang Mo; Ye Lin; Chenggang Ji; Zhixiang Jian
Journal:  World J Surg Oncol       Date:  2020-07-25       Impact factor: 2.754

6.  Two new inflammatory markers related to the CURB-65 score for disease severity in patients with community-acquired pneumonia: The hypersensitive C-reactive protein to albumin ratio and fibrinogen to albumin ratio.

Authors:  Bing Luo; Minjie Sun; Xingxing Huo; Yun Wang
Journal:  Open Life Sci       Date:  2021-01-22       Impact factor: 0.938

7.  Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.

Authors:  Dongdong Wu; Xingmu Wang; Ge Shi; Honggang Sun; Guoxing Ge
Journal:  Aging (Albany NY)       Date:  2021-01-06       Impact factor: 5.682

8.  C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms.

Authors:  Anna Nießen; Simon Schimmack; Marta Sandini; Dominik Fliegner; Ulf Hinz; Magdalena Lewosinska; Thilo Hackert; Markus W Büchler; Oliver Strobel
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

9.  Comparison of the Clinical Value of the Geriatric Nutritional Risk Index and Prognostic Nutritional Index as Determinants of Survival Outcome in Patients with Gastric Cancer.

Authors:  Soomin An; Wankyu Eo; Sookyung Lee
Journal:  J Cancer       Date:  2022-09-21       Impact factor: 4.478

10.  Preoperative Serum Hypersensitive-c-Reactive-Protein (Hs-CRP) to Albumin Ratio Predicts Survival in Patients with Luminal B Subtype Breast Cancer.

Authors:  Xiujun Liu; Xiuchun Guo; Zhiqiang Zhang
Journal:  Onco Targets Ther       Date:  2021-07-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.